Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

Research findings point to inherited genetic basis of ALL risk in children

Research findings point to inherited genetic basis of ALL risk in children

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Scientists discover ribosomal protein-based cancer signature

Scientists discover ribosomal protein-based cancer signature

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Simple, coordinated approach can improve chances of survival for high-risk AML patients

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New report estimates global burden of cancer cases and deaths in 2015

New report estimates global burden of cancer cases and deaths in 2015

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Study reveals new way to improve stability of common protein drugs

Study reveals new way to improve stability of common protein drugs

New study finds smoking cessation at any age reduces risk of death

New study finds smoking cessation at any age reduces risk of death

Study sheds light on why new drug is effective in combating leukaemia

Study sheds light on why new drug is effective in combating leukaemia

Preventative strategy in stem cell transplant recipients may help thwart C. diff infections

Preventative strategy in stem cell transplant recipients may help thwart C. diff infections

TUM scientists uncover molecular mechanisms of inhibitors that can selectively thwart immunoproteasome

TUM scientists uncover molecular mechanisms of inhibitors that can selectively thwart immunoproteasome

Researchers reveal mechanism for side effects of drug used for treating hematological malignancies

Researchers reveal mechanism for side effects of drug used for treating hematological malignancies

Cancer gene mutations can predict response to less intensive treatment in AML patients

Cancer gene mutations can predict response to less intensive treatment in AML patients

HSCI researchers use color tagging system to track development of blood stem cells

HSCI researchers use color tagging system to track development of blood stem cells

Researchers uncover new clues that may help combat leukemia and other B cell cancers

Researchers uncover new clues that may help combat leukemia and other B cell cancers

New color-coding tool sheds light on blood disorders, cancers by tracking clonal stem cells

New color-coding tool sheds light on blood disorders, cancers by tracking clonal stem cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.